MAPP

MAP Pharmaceuticals, Inc.CIK 1401923 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for MAPP PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for MAPP

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
ARMER THOMAS A	Chief Scientific Officer	29	$0	$2.72M	2015-01-25
Borland Scott	SVP, Neurology Franchise	35	$0	$18.9K	2013-03-01
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	22	$0	$0	2013-03-01
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	46	$0	$1.80M	2013-03-01
Friedman Charlene A	SVP, Gen Counsel & Sec	23	$0	$175.0K	2013-03-01
Wolff Henry Ward	Director	6	$0	$0	2013-03-01
OSHEA WILLIAM J	Director	2	$0	$0	2013-03-01
NELSON TIMOTHY S	President and CEO	20	$0	$1.98M	2013-03-01
HENWOOD GERALDINE	Director	15	$0	$328.6K	2013-03-01
MCPHERRON MATTHEW V	Director	7	$0	$0	2013-03-01
KELLEY BERNARD J	Director	7	$0	$0	2013-03-01
WARD SCOTT R	Director	7	$0	$0	2013-03-01
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affairs	20	$0	$35.3K	2013-03-01

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
ARMER THOMAS A	Chief Scientific Officer	F Tax w/h	2015-01-25	2013-01-29	1,034	$24.75	$25.6K	130,878	SEC↗
HENWOOD GERALDINE	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
HENWOOD GERALDINE	Director	D To issuer deriv	2013-03-01	2013-03-04	5,000	—	$0	0	SEC↗
HENWOOD GERALDINE	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
OSHEA WILLIAM J	Director	D To issuer deriv	2013-03-01	2013-03-04	20,000	—	$0	0	SEC↗
WARD SCOTT R	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
WARD SCOTT R	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
WARD SCOTT R	Director	D To issuer deriv	2013-03-01	2013-03-04	10,000	—	$0	0	SEC↗
WARD SCOTT R	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
WARD SCOTT R	Director	D To issuer deriv	2013-03-01	2013-03-04	30,000	—	$0	0	SEC↗
Wolff Henry Ward	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
Wolff Henry Ward	Director	D To issuer deriv	2013-03-01	2013-03-04	30,000	—	$0	0	SEC↗
Wolff Henry Ward	Director	D To issuer deriv	2013-03-01	2013-03-04	10,000	—	$0	0	SEC↗
Wolff Henry Ward	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
Wolff Henry Ward	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	1,589	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	1,648	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	300	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	8,250	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	750	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	3,375	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	3,500	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	3,000	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	1,800	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	4,375	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	5,000	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	2,500	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	4,237	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	248	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	32,500	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	13,750	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	21,000	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	35,000	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	51,500	—	$0	0	SEC↗
Borland Scott	SVP, Neurology Franchise	D To issuer deriv	2013-03-01	2013-03-04	10,000	—	$0	0	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	D To issuer deriv	2013-03-01	2013-03-04	27,500	—	$0	0	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	D To issuer deriv	2013-03-01	2013-03-04	4,500	—	$0	0	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	D To issuer deriv	2013-03-01	2013-03-04	32,500	—	$0	0	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	D To issuer deriv	2013-03-01	2013-03-04	8,250	—	$0	0	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	D To issuer deriv	2013-03-01	2013-03-04	55,000	—	$0	0	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	D To issuer deriv	2013-03-01	2013-03-04	29,500	—	$0	0	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	D To issuer deriv	2013-03-01	2013-03-04	61,450	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	D To issuer deriv	2013-03-01	2013-03-04	8,250	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	D To issuer deriv	2013-03-01	2013-03-04	4,500	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	D To issuer deriv	2013-03-01	2013-03-04	32,500	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	D To issuer deriv	2013-03-01	2013-03-04	27,500	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	D To issuer deriv	2013-03-01	2013-03-04	45,000	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	D To issuer deriv	2013-03-01	2013-03-04	50,000	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	D To issuer deriv	2013-03-01	2013-03-04	40,000	—	$0	0	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	D To issuer deriv	2013-03-01	2013-03-04	55,000	—	$0	0	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	D To issuer deriv	2013-03-01	2013-03-04	4,500	—	$0	0	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	D To issuer deriv	2013-03-01	2013-03-04	32,500	—	$0	0	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	D To issuer deriv	2013-03-01	2013-03-04	27,500	—	$0	0	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	D To issuer deriv	2013-03-01	2013-03-04	8,250	—	$0	0	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	D To issuer deriv	2013-03-01	2013-03-04	50,805	—	$0	0	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	D To issuer deriv	2013-03-01	2013-03-04	30,000	—	$0	0	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	D To issuer deriv	2013-03-01	2013-03-04	74,744	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	D To issuer deriv	2013-03-01	2013-03-04	8,250	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	D To issuer deriv	2013-03-01	2013-03-04	4,500	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	D To issuer deriv	2013-03-01	2013-03-04	32,500	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	D To issuer deriv	2013-03-01	2013-03-04	27,500	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	D To issuer deriv	2013-03-01	2013-03-04	50,000	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	D To issuer deriv	2013-03-01	2013-03-04	75,000	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	D To issuer deriv	2013-03-01	2013-03-04	50,000	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	D To issuer deriv	2013-03-01	2013-03-04	22,526	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	D To issuer deriv	2013-03-01	2013-03-04	40,847	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	200,000	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	71,509	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	132,549	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	28,125	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	112,500	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	179,176	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	100,000	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	175,000	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	160,000	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	180,790	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	D To issuer deriv	2013-03-01	2013-03-04	121,468	—	$0	0	SEC↗
KELLEY BERNARD J	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
KELLEY BERNARD J	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
KELLEY BERNARD J	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
KELLEY BERNARD J	Director	D To issuer deriv	2013-03-01	2013-03-04	10,000	—	$0	0	SEC↗
KELLEY BERNARD J	Director	D To issuer deriv	2013-03-01	2013-03-04	7,500	—	$0	0	SEC↗
KELLEY BERNARD J	Director	D To issuer deriv	2013-03-01	2013-03-04	16,949	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	75,000	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	4,500	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	32,500	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	27,500	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	55,000	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	8,250	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	60,000	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	47,296	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	11,299	—	$0	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-04	23,122	—	$0	0	SEC↗
MCPHERRON MATTHEW V	Director	D To issuer deriv	2013-03-01	2013-03-05	7,500	—	$0	0	SEC↗
MCPHERRON MATTHEW V	Director	D To issuer deriv	2013-03-01	2013-03-05	7,500	—	$0	0	SEC↗
MCPHERRON MATTHEW V	Director	D To issuer deriv	2013-03-01	2013-03-05	7,500	—	$0	0	SEC↗
MCPHERRON MATTHEW V	Director	D To issuer deriv	2013-03-01	2013-03-05	10,000	—	$0	0	SEC↗
MCPHERRON MATTHEW V	Director	D To issuer deriv	2013-03-01	2013-03-05	7,500	—	$0	0	SEC↗
WARD SCOTT R	Director	U Tender	2013-03-01	2013-03-04	2,000	$25.00	$50.0K	0	SEC↗
Borland Scott	SVP, Neurology Franchise	U Tender	2013-03-01	2013-03-04	12,951	$25.00	$323.8K	0	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	U Tender	2013-03-01	2013-03-04	3,795	$25.00	$94.9K	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	U Tender	2013-03-01	2013-03-04	18,438	$25.00	$460.9K	0	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	U Tender	2013-03-01	2013-03-04	4,229	$25.00	$105.7K	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	U Tender	2013-03-01	2013-03-04	222,676	$25.00	$5.57M	0	SEC↗
NELSON TIMOTHY S	President and CEO	U Tender	2013-03-01	2013-03-04	38,740	$25.00	$968.5K	0	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	U Tender	2013-03-01	2013-03-04	14,220	$25.00	$355.5K	0	SEC↗
MCPHERRON MATTHEW V	Director	U Tender	2013-03-01	2013-03-05	2,999,526	$25.00	$74.99M	0	SEC↗
HENWOOD GERALDINE	Director	M Exercise deriv	2013-02-28	2013-03-04	2,500	—	$0	5,000	SEC↗
HENWOOD GERALDINE	Director	M Exercise deriv	2013-02-28	2013-03-04	7,500	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise deriv	2013-02-28	2013-03-04	20,000	—	$0	50,000	SEC↗
HENWOOD GERALDINE	Director	M Exercise	2013-02-28	2013-03-04	2,500	$11.69	$29.2K	2,500	SEC↗
HENWOOD GERALDINE	Director	S Sale	2013-02-28	2013-03-04	10,000	$25.00	$250.0K	0	SEC↗
HENWOOD GERALDINE	Director	M Exercise	2013-02-28	2013-03-04	7,500	$12.19	$91.4K	10,000	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	S Sale	2013-02-28	2013-03-04	20,000	$25.00	$500.0K	18,438	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise	2013-02-28	2013-03-04	20,000	$10.37	$207.4K	38,438	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	S Sale	2013-02-01	2013-02-04	1,429	$24.73	$35.3K	3,479	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	M Exercise deriv	2013-01-26	2013-01-29	2,250	—	$0	4,500	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	M Exercise deriv	2013-01-26	2013-01-29	2,250	—	$0	4,500	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	M Exercise deriv	2013-01-26	2013-01-29	2,250	—	$0	4,500	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise deriv	2013-01-26	2013-01-29	2,250	—	$0	4,500	SEC↗
ARMER THOMAS A	Chief Scientific Officer	M Exercise deriv	2013-01-26	2013-01-29	2,250	—	$0	4,500	SEC↗
Borland Scott	SVP, Neurology Franchise	M Exercise deriv	2013-01-26	2013-01-29	1,900	—	$0	3,800	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	F Tax w/h	2013-01-26	2013-01-29	871	$24.75	$21.6K	4,908	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	M Exercise	2013-01-26	2013-01-29	2,250	—	$0	5,779	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	F Tax w/h	2013-01-26	2013-01-29	873	$24.75	$21.6K	13,899	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	M Exercise	2013-01-26	2013-01-29	2,250	—	$0	14,772	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	F Tax w/h	2013-01-26	2013-01-29	871	$24.75	$21.6K	4,229	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	M Exercise	2013-01-26	2013-01-29	2,250	—	$0	5,100	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise	2013-01-26	2013-01-29	2,250	—	$0	18,296	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	F Tax w/h	2013-01-26	2013-01-29	846	$24.75	$20.9K	17,450	SEC↗
ARMER THOMAS A	Chief Scientific Officer	M Exercise	2013-01-26	2013-01-29	2,250	—	$0	133,128	SEC↗
ARMER THOMAS A	Chief Scientific Officer	F Tax w/h	2013-01-26	2013-01-29	846	$24.75	$20.9K	132,282	SEC↗
Borland Scott	SVP, Neurology Franchise	S Sale	2013-01-26	2013-01-29	764	$24.75	$18.9K	12,294	SEC↗
Borland Scott	SVP, Neurology Franchise	M Exercise	2013-01-26	2013-01-29	1,900	—	$0	13,058	SEC↗
NELSON TIMOTHY S	President and CEO	M Exercise deriv	2013-01-25	2013-01-29	9,375	—	$0	28,125	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	M Exercise deriv	2013-01-25	2013-01-29	2,750	—	$0	8,250	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	M Exercise deriv	2013-01-25	2013-01-29	2,750	—	$0	8,250	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	M Exercise deriv	2013-01-25	2013-01-29	2,750	—	$0	8,250	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise deriv	2013-01-25	2013-01-29	2,750	—	$0	8,250	SEC↗
ARMER THOMAS A	Chief Scientific Officer	M Exercise deriv	2013-01-25	2013-01-29	2,750	—	$0	8,250	SEC↗
Borland Scott	SVP, Neurology Franchise	M Exercise deriv	2013-01-25	2013-01-29	3,000	—	$0	9,000	SEC↗
NELSON TIMOTHY S	President and CEO	M Exercise	2013-01-25	2013-01-29	9,375	—	$0	42,392	SEC↗
NELSON TIMOTHY S	President and CEO	F Tax w/h	2013-01-25	2013-01-29	3,652	$24.75	$90.4K	38,740	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	F Tax w/h	2013-01-25	2013-01-29	1,207	$24.75	$29.9K	3,529	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	M Exercise	2013-01-25	2013-01-29	2,750	—	$0	4,736	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	M Exercise	2013-01-25	2013-01-29	2,750	—	$0	13,729	SEC↗
CHAI CHRISTOPHER Y	SVP, Chief Financial Officer	F Tax w/h	2013-01-25	2013-01-29	1,207	$24.75	$29.9K	12,522	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	F Tax w/h	2013-01-25	2013-01-29	1,207	$24.75	$29.9K	2,850	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	M Exercise	2013-01-25	2013-01-29	2,750	—	$0	4,057	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	F Tax w/h	2013-01-25	2013-01-29	1,034	$24.75	$25.6K	16,046	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise	2013-01-25	2013-01-29	2,750	—	$0	17,080	SEC↗
ARMER THOMAS A	Chief Scientific Officer	M Exercise	2013-01-25	2013-01-29	2,750	—	$0	131,912	SEC↗
Borland Scott	SVP, Neurology Franchise	F Tax w/h	2013-01-25	2013-01-29	1,317	$24.75	$32.6K	11,158	SEC↗
Borland Scott	SVP, Neurology Franchise	M Exercise	2013-01-25	2013-01-29	3,000	—	$0	12,475	SEC↗
NELSON TIMOTHY S	President and CEO	M Exercise deriv	2013-01-23	2013-01-25	80,000	—	$0	132,549	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise deriv	2013-01-23	2013-01-25	30,000	—	$0	57,244	SEC↗
ARMER THOMAS A	Chief Scientific Officer	M Exercise deriv	2013-01-23	2013-01-25	39,620	—	$0	0	SEC↗
NELSON TIMOTHY S	President and CEO	S Sale	2013-01-23	2013-01-25	80,000	$24.76	$1.98M	33,017	SEC↗
NELSON TIMOTHY S	President and CEO	M Exercise	2013-01-23	2013-01-25	80,000	$0.64	$51.2K	113,017	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	S Sale	2013-01-23	2013-01-25	30,000	$24.76	$742.8K	14,330	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise	2013-01-23	2013-01-25	30,000	$10.37	$311.1K	44,330	SEC↗
ARMER THOMAS A	Chief Scientific Officer	M Exercise	2013-01-23	2013-01-25	39,620	$6.39	$253.2K	188,782	SEC↗
ARMER THOMAS A	Chief Scientific Officer	S Sale	2013-01-23	2013-01-25	59,620	$24.76	$1.48M	129,162	SEC↗
HENWOOD GERALDINE	Director	M Exercise deriv	2012-11-23	2012-11-27	3,750	—	$0	0	SEC↗
HENWOOD GERALDINE	Director	M Exercise deriv	2012-11-23	2012-11-27	1,490	—	$0	0	SEC↗
HENWOOD GERALDINE	Director	M Exercise	2012-11-23	2012-11-27	1,490	$0.74	$1.1K	1,490	SEC↗
HENWOOD GERALDINE	Director	S Sale	2012-11-23	2012-11-27	3,750	$15.00	$56.3K	0	SEC↗
HENWOOD GERALDINE	Director	M Exercise	2012-11-23	2012-11-27	3,750	$3.18	$11.9K	3,750	SEC↗
HENWOOD GERALDINE	Director	S Sale	2012-11-23	2012-11-27	1,490	$15.00	$22.4K	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise deriv	2012-11-01	2012-11-05	5,767	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	S Sale	2012-11-01	2012-11-05	5,767	$15.64	$90.2K	12,385	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise	2012-11-01	2012-11-05	5,767	$6.39	$36.9K	18,152	SEC↗
Borland Scott	SVP, Neurology Franchise	M Exercise deriv	2012-06-07	2012-06-08	1,125	—	$0	3,375	SEC↗
Borland Scott	SVP, Neurology Franchise	M Exercise	2012-06-07	2012-06-08	1,125	—	$0	7,592	SEC↗
Borland Scott	SVP, Neurology Franchise	F Tax w/h	2012-06-07	2012-06-08	414	$12.01	$5.0K	7,178	SEC↗
MCPHERRON MATTHEW V	Director	A Award deriv	2012-05-17	2012-05-18	10,000	—	$0	10,000	SEC↗
KELLEY BERNARD J	Director	A Award deriv	2012-05-17	2012-05-21	10,000	—	$0	10,000	SEC↗
HENWOOD GERALDINE	Director	A Award deriv	2012-05-17	2012-05-21	10,000	—	$0	10,000	SEC↗
WARD SCOTT R	Director	A Award deriv	2012-05-17	2012-05-21	10,000	—	$0	10,000	SEC↗
Wolff Henry Ward	Director	A Award deriv	2012-05-17	2012-05-21	10,000	—	$0	10,000	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise deriv	2012-04-02	2012-04-04	2,500	—	$0	5,767	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	S Sale	2012-04-02	2012-04-04	2,500	$14.38	$36.0K	12,385	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise	2012-04-02	2012-04-04	2,500	$6.39	$16.0K	14,885	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	M Exercise deriv	2012-03-09	2012-03-13	10,000	—	$0	22,328	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise deriv	2012-03-09	2012-03-13	10,000	—	$0	8,267	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	S Sale	2012-03-09	2012-03-13	10,000	$17.50	$175.0K	1,307	SEC↗
Friedman Charlene A	SVP, Gen Counsel & Sec	M Exercise	2012-03-09	2012-03-13	10,000	$12.37	$123.7K	11,307	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	S Sale	2012-03-09	2012-03-13	10,000	$17.50	$175.0K	12,385	SEC↗
GIANAKAKOS ANASTASIOS	SVP, Chief Business Officer	M Exercise	2012-03-09	2012-03-13	10,000	$6.39	$63.9K	22,385	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise deriv	2012-02-21	2012-02-22	1,385	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise deriv	2012-02-21	2012-02-22	1,115	—	$0	18,267	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	S Sale	2012-02-21	2012-02-22	1,385	$15.99	$22.1K	12,385	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise	2012-02-21	2012-02-22	1,385	$6.39	$8.9K	13,770	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	S Sale	2012-02-21	2012-02-22	1,115	$16.02	$17.9K	12,385	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise	2012-02-21	2012-02-22	1,115	$6.39	$7.1K	13,500	SEC↗
ARMER THOMAS A	Chief Scientific Officer	S Sale	2012-02-14	2012-02-14	30,999	$15.62	$484.2K	149,162	SEC↗
ARMER THOMAS A	Chief Scientific Officer	S Sale	2012-02-13	2012-02-14	2,800	$16.00	$44.8K	180,161	SEC↗
ARMER THOMAS A	Chief Scientific Officer	S Sale	2012-02-08	2012-02-10	26,201	$16.00	$419.2K	182,961	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise deriv	2012-02-06	2012-02-07	10,000	—	$0	0	SEC↗
ARMER THOMAS A	Chief Scientific Officer	S Sale	2012-02-06	2012-02-07	19,868	$15.00	$298.0K	209,162	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	S Sale	2012-02-06	2012-02-07	10,000	$15.00	$150.0K	12,385	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise	2012-02-06	2012-02-07	10,000	$6.39	$63.9K	22,385	SEC↗
ARMER THOMAS A	Chief Scientific Officer	S Sale	2012-02-03	2012-02-07	132	$15.00	$2.0K	229,030	SEC↗
Friedman Charlene A	SVP President, Gen Counsel&S	M Exercise deriv	2012-01-26	2012-01-27	2,250	—	$0	6,750	SEC↗
CHAI CHRISTOPHER Y	SVP & CFO	M Exercise deriv	2012-01-26	2012-01-27	2,250	—	$0	6,750	SEC↗
Borland Scott	SVP, Neurology Franchise	M Exercise deriv	2012-01-26	2012-01-27	1,900	—	$0	5,700	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise deriv	2012-01-26	2012-01-27	2,250	—	$0	1,307	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	M Exercise deriv	2012-01-26	2012-01-27	2,250	—	$0	6,750	SEC↗
ARMER THOMAS A	Chief Scientific Officer	M Exercise deriv	2012-01-26	2012-01-27	2,250	—	$0	6,750	SEC↗
Friedman Charlene A	SVP President, Gen Counsel&S	F Tax w/h	2012-01-26	2012-01-27	943	$13.84	$13.1K	1,307	SEC↗
Friedman Charlene A	SVP President, Gen Counsel&S	M Exercise	2012-01-26	2012-01-27	2,250	—	$0	2,250	SEC↗
CHAI CHRISTOPHER Y	SVP & CFO	M Exercise	2012-01-26	2012-01-27	2,250	—	$0	10,813	SEC↗
CHAI CHRISTOPHER Y	SVP & CFO	F Tax w/h	2012-01-26	2012-01-27	943	$13.84	$13.1K	9,870	SEC↗
Borland Scott	SVP, Neurology Franchise	M Exercise	2012-01-26	2012-01-27	1,900	—	$0	7,263	SEC↗
Borland Scott	SVP, Neurology Franchise	F Tax w/h	2012-01-26	2012-01-27	796	$13.84	$11.0K	6,467	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	F Tax w/h	2012-01-26	2012-01-27	943	$13.84	$13.1K	12,385	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise	2012-01-26	2012-01-27	2,250	—	$0	13,328	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	M Exercise	2012-01-26	2012-01-27	2,250	—	$0	2,372	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	F Tax w/h	2012-01-26	2012-01-27	943	$13.84	$13.1K	1,429	SEC↗
ARMER THOMAS A	Chief Scientific Officer	F Tax w/h	2012-01-26	2012-01-27	943	$13.84	$13.1K	229,162	SEC↗
ARMER THOMAS A	Chief Scientific Officer	M Exercise	2012-01-26	2012-01-27	2,250	—	$0	230,105	SEC↗
Friedman Charlene A	SVP President, Gen Counsel&S	A Award deriv	2012-01-25	2012-01-27	32,500	—	$0	32,500	SEC↗
Friedman Charlene A	SVP President, Gen Counsel&S	A Award deriv	2012-01-25	2012-01-27	11,000	—	$0	11,000	SEC↗
CHAI CHRISTOPHER Y	SVP & CFO	A Award deriv	2012-01-25	2012-01-27	11,000	—	$0	11,000	SEC↗
CHAI CHRISTOPHER Y	SVP & CFO	A Award deriv	2012-01-25	2012-01-27	32,500	—	$0	32,500	SEC↗
Borland Scott	SVP, Neurology Franchise	A Award deriv	2012-01-25	2012-01-27	12,000	—	$0	12,000	SEC↗
Borland Scott	SVP, Neurology Franchise	A Award deriv	2012-01-25	2012-01-27	35,500	—	$0	35,500	SEC↗
NELSON TIMOTHY S	President and CEO	A Award deriv	2012-01-25	2012-01-27	37,500	—	$0	37,500	SEC↗
NELSON TIMOTHY S	President and CEO	A Award deriv	2012-01-25	2012-01-27	112,500	—	$0	112,500	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	A Award deriv	2012-01-25	2012-01-27	32,500	—	$0	32,500	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	A Award deriv	2012-01-25	2012-01-27	11,000	—	$0	11,000	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	A Award deriv	2012-01-25	2012-01-27	32,500	—	$0	32,500	SEC↗
KELLERMAN DONALD J	SVP,Clinical Dev & Med Affai	A Award deriv	2012-01-25	2012-01-27	11,000	—	$0	11,000	SEC↗
ARMER THOMAS A	Chief Scientific Officer	A Award deriv	2012-01-25	2012-01-27	32,500	—	$0	32,500	SEC↗
ARMER THOMAS A	Chief Scientific Officer	A Award deriv	2012-01-25	2012-01-27	11,000	—	$0	11,000	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise deriv	2012-01-19	2012-01-20	4,471	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	S Sale	2012-01-19	2012-01-20	4,471	$13.88	$62.1K	9,316	SEC↗
GIANAKAKOS ANASTASIOS	SVP & Chief Business Officer	M Exercise	2012-01-19	2012-01-20	4,471	$0.74	$3.3K	13,787	SEC↗
OSHEA WILLIAM J	Director	A Award deriv	2012-01-13	2012-01-17	20,000	—	$0	20,000	SEC↗